S&P 500   4,534.80 (-0.03%)
DOW   35,512.79 (-0.27%)
QQQ   375.03 (+0.01%)
AAPL   149.48 (+0.15%)
MSFT   308.13 (+0.23%)
FB   340.35 (-0.13%)
GOOGL   2,828.00 (-0.26%)
TSLA   882.27 (+1.90%)
AMZN   3,422.76 (+0.23%)
NVDA   222.71 (+0.76%)
BABA   178.50 (+0.75%)
NIO   40.28 (+1.26%)
CGC   14.49 (+2.69%)
GE   105.39 (-0.58%)
AMD   117.51 (+0.96%)
MU   68.07 (-0.29%)
T   26.00 (+0.35%)
F   16.54 (+3.12%)
ACB   7.83 (+2.22%)
DIS   171.52 (+0.57%)
PFE   42.56 (-0.56%)
BA   217.54 (+0.63%)
AMC   41.51 (+1.54%)
S&P 500   4,534.80 (-0.03%)
DOW   35,512.79 (-0.27%)
QQQ   375.03 (+0.01%)
AAPL   149.48 (+0.15%)
MSFT   308.13 (+0.23%)
FB   340.35 (-0.13%)
GOOGL   2,828.00 (-0.26%)
TSLA   882.27 (+1.90%)
AMZN   3,422.76 (+0.23%)
NVDA   222.71 (+0.76%)
BABA   178.50 (+0.75%)
NIO   40.28 (+1.26%)
CGC   14.49 (+2.69%)
GE   105.39 (-0.58%)
AMD   117.51 (+0.96%)
MU   68.07 (-0.29%)
T   26.00 (+0.35%)
F   16.54 (+3.12%)
ACB   7.83 (+2.22%)
DIS   171.52 (+0.57%)
PFE   42.56 (-0.56%)
BA   217.54 (+0.63%)
AMC   41.51 (+1.54%)
S&P 500   4,534.80 (-0.03%)
DOW   35,512.79 (-0.27%)
QQQ   375.03 (+0.01%)
AAPL   149.48 (+0.15%)
MSFT   308.13 (+0.23%)
FB   340.35 (-0.13%)
GOOGL   2,828.00 (-0.26%)
TSLA   882.27 (+1.90%)
AMZN   3,422.76 (+0.23%)
NVDA   222.71 (+0.76%)
BABA   178.50 (+0.75%)
NIO   40.28 (+1.26%)
CGC   14.49 (+2.69%)
GE   105.39 (-0.58%)
AMD   117.51 (+0.96%)
MU   68.07 (-0.29%)
T   26.00 (+0.35%)
F   16.54 (+3.12%)
ACB   7.83 (+2.22%)
DIS   171.52 (+0.57%)
PFE   42.56 (-0.56%)
BA   217.54 (+0.63%)
AMC   41.51 (+1.54%)
S&P 500   4,534.80 (-0.03%)
DOW   35,512.79 (-0.27%)
QQQ   375.03 (+0.01%)
AAPL   149.48 (+0.15%)
MSFT   308.13 (+0.23%)
FB   340.35 (-0.13%)
GOOGL   2,828.00 (-0.26%)
TSLA   882.27 (+1.90%)
AMZN   3,422.76 (+0.23%)
NVDA   222.71 (+0.76%)
BABA   178.50 (+0.75%)
NIO   40.28 (+1.26%)
CGC   14.49 (+2.69%)
GE   105.39 (-0.58%)
AMD   117.51 (+0.96%)
MU   68.07 (-0.29%)
T   26.00 (+0.35%)
F   16.54 (+3.12%)
ACB   7.83 (+2.22%)
DIS   171.52 (+0.57%)
PFE   42.56 (-0.56%)
BA   217.54 (+0.63%)
AMC   41.51 (+1.54%)
NASDAQ:SILK

Silk Road Medical Stock Forecast, Price & News

$56.75
-0.82 (-1.42 %)
(As of 10/20/2021 04:00 PM ET)
Add
Compare
Today's Range
$55.98
$57.63
50-Day Range
$47.34
$65.80
52-Week Range
$43.11
$75.80
Volume95,473 shs
Average Volume331,403 shs
Market Capitalization$1.97 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.51
30 days | 90 days | 365 days | Advanced Chart
Receive SILK News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.


Silk Road Medical logo

About Silk Road Medical

Silk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. Its products include ENROUTE transcarotid neuroprotection system, ENROUTE transcarotid stent system, and ENROUTE transcarotid peripheral access kit. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SILK
Employees
281
Year Founded
N/A

Sales & Book Value

Annual Sales
$75.23 million
Book Value
$3.17 per share

Profitability

Net Income
$-47.37 million

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$1.97 billion
Next Earnings Date
11/9/2021 (Estimated)
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.37 out of 5 stars

Medical Sector

1105th out of 1,360 stocks

Surgical & Medical Instruments Industry

106th out of 124 stocks

Analyst Opinion: 1.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -












Silk Road Medical (NASDAQ:SILK) Frequently Asked Questions

Is Silk Road Medical a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Silk Road Medical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares.
View analyst ratings for Silk Road Medical
or view top-rated stocks.

What stocks does MarketBeat like better than Silk Road Medical?

Wall Street analysts have given Silk Road Medical a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Silk Road Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Silk Road Medical?

Silk Road Medical saw a drop in short interest in the month of September. As of September 15th, there was short interest totaling 1,840,000 shares, a drop of 15.2% from the August 31st total of 2,170,000 shares. Based on an average daily trading volume, of 318,500 shares, the days-to-cover ratio is presently 5.8 days. Approximately 5.5% of the company's shares are sold short.
View Silk Road Medical's Short Interest
.

When is Silk Road Medical's next earnings date?

Silk Road Medical is scheduled to release its next quarterly earnings announcement on Tuesday, November 9th 2021.
View our earnings forecast for Silk Road Medical
.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) released its quarterly earnings data on Thursday, July, 29th. The company reported ($0.31) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.37) by $0.06. The business had revenue of $26.46 million for the quarter, compared to analyst estimates of $25.33 million. Silk Road Medical had a negative trailing twelve-month return on equity of 45.52% and a negative net margin of 53.85%.
View Silk Road Medical's earnings history
.

How has Silk Road Medical's stock been impacted by Coronavirus (COVID-19)?

Silk Road Medical's stock was trading at $37.14 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SILK shares have increased by 52.8% and is now trading at $56.75.
View which stocks have been most impacted by COVID-19
.

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical issued an update on its FY 2021 earnings guidance on Thursday, August, 5th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $104 million-$109 million, compared to the consensus revenue estimate of $106.04 million.

What price target have analysts set for SILK?

3 Wall Street analysts have issued 12-month target prices for Silk Road Medical's shares. Their forecasts range from $50.00 to $55.00. On average, they anticipate Silk Road Medical's share price to reach $52.50 in the next year. This suggests that the stock has a possible downside of 7.5%.
View analysts' price targets for Silk Road Medical
or view top-rated stocks among Wall Street analysts.

Who are Silk Road Medical's key executives?

Silk Road Medical's management team includes the following people:
  • Erica J. Rogers, President, Chief Executive Officer & Director (LinkedIn Profile)
  • Lucas W. Buchanan, Chief Financial & Operating Officer
  • Sumaira Macdonald, Executive Medical Director
  • Tammy Leitsinger, VP-Professional Education & Medical Affairs
  • Robert A. Nicholas, Vice President-Operations & Engineering

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), The Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), Honeywell International (HON), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

When did Silk Road Medical IPO?

(SILK) raised $75 million in an IPO on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

Who are Silk Road Medical's major shareholders?

Silk Road Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Kestra Advisory Services LLC (0.01%), ProVise Management Group LLC (0.01%) and McAdam LLC (0.01%). Company insiders that own Silk Road Medical stock include Andrew S Davis, Andrew S Davis, Erica J Rogers, Erica J Rogers, Jack W Lasersohn, Lucas W Buchanan, Pincus & Co Warburg and Richard Ruedy.
View institutional ownership trends for Silk Road Medical
.

Which major investors are selling Silk Road Medical stock?

SILK stock was sold by a variety of institutional investors in the last quarter, including ProVise Management Group LLC. Company insiders that have sold Silk Road Medical company stock in the last year include Andrew S Davis, Erica J Rogers, Jack W Lasersohn, Lucas W Buchanan, and Richard Ruedy.
View insider buying and selling activity for Silk Road Medical
or view top insider-selling stocks.

Which major investors are buying Silk Road Medical stock?

SILK stock was bought by a variety of institutional investors in the last quarter, including Kestra Advisory Services LLC, and McAdam LLC.
View insider buying and selling activity for Silk Road Medical
or or view top insider-buying stocks.

How do I buy shares of Silk Road Medical?

Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $56.75.

How much money does Silk Road Medical make?

Silk Road Medical has a market capitalization of $1.97 billion and generates $75.23 million in revenue each year. The company earns $-47.37 million in net income (profit) each year or ($1.44) on an earnings per share basis.

How many employees does Silk Road Medical have?

Silk Road Medical employs 281 workers across the globe.

What is Silk Road Medical's official website?

The official website for Silk Road Medical is www.silkroadmed.com.

Where are Silk Road Medical's headquarters?

Silk Road Medical is headquartered at 1213 INNSBRUCK DR., SUNNYVALE CA, 94089.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The company can be reached via phone at (408) 720-9002 or via email at [email protected].


This page was last updated on 10/21/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.